← Back to directory

G. Kees Hovingh

Researcher Next ID · RN-006731

Researcher · Medicine

Novo Nordisk (Denmark)

Copenhagen, Denmark

Not currently recruitingFunding unknown
Works count
338
Citation count
33,892
H-index
77
i10-index
212

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lipoproteins and Cardiovascular Health
Diabetes, Cardiovascular Risks, and Lipoproteins
Cholesterol and Lipid Metabolism
Cancer, Lipids, and Metabolism
Genetic Associations and Epidemiology

Publications

  • Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

    New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2307563

  • Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity

    New England Journal of Medicine · 2023 · https://doi.org/10.1056/nejmoa2306963

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    European Heart Journal · 2015 · https://doi.org/10.1093/eurheartj/ehv043

  • Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

    European Heart Journal · 2015 · https://doi.org/10.1093/eurheartj/ehv043

  • Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

    European Heart Journal · 2014 · https://doi.org/10.1093/eurheartj/ehu274

Current projects

    No projects listed.